Stroke-Like Migraine after Radiation Treatment Syndrome in Children with CancerFunding This study was supported by Cancer Center Support Grant [CA21765] from the National Cancer Institute, and by the American Libyan Syrian Associated Charities.
Stroke-like migraine attacks after radiation therapy (SMART) syndrome is a symptom complex of transient neurological deficits, headache, and abnormal cortical contrast enhancement on brain MRI. Pathophysiology is unclear, but exposure to cranial radiation (RT) is a sine qua non. We report five children with SMART syndrome treated with RT therapy for medulloblastoma (n = 3), atypical teratoid rhabdoid tumor (n = 1), and pleomorphic xanthoastrocytoma (n = 1). Median age at tumor diagnosis was 9.4 years (range 5.1–14.7). Median follow-up from cancer diagnosis was 3.1 years (range 1.4–12.9). All patients had 54 Gy focal RT treatment and medulloblastoma children had additional 36 Gy craniospinal irradiation. Median time from the end of RT to first transient neurological deficit was 1 year (range 0.7–12.1). The median follow-up since first SMART episode was 0.6 years (range 0.3–2.6). Presenting symptoms included the gradual development of unilateral weakness (n = 4), non-fluent dysphasia (n = 1), somnolence (n = 1), and headaches (n = 3). Neurological deficits resolved within 30 minutes to 10 days. Transient cortical enhancement on magnetic resonance imaging (MRI) was confirmed in two children and was absent in the other three. Two children had a single and three had multiple episodes over the next few months. Two children with protracted symptoms responded to 3 days treatment with high dose intravenous methylprednisolone. Symptoms ultimately resolved in all patients. SMART syndrome is a rare disorder characterized by slow evolution of neurological deficits with variable abnormal cortical contrast enhancement. The use of steroids may improve symptoms and speed resolution.
Q.S.A. collected the data and wrote the first draft. R.B.K. reviewed imaging and edited the manuscript. All other authors read and edited the manuscript.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Eingereicht: 14. Juli 2021
Angenommen: 03. November 2021
Artikel online veröffentlicht:
20. Dezember 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Shuper A, Packer RJ, Vezina LG, Nicholson HS, Lafond D. ‘Complicated migraine-like episodes’ in children following cranial irradiation and chemotherapy. Neurology 1995; 45 (10) 1837-1840
- 2 Zheng Q, Yang L, Tan LM, Qin LX, Wang CY, Zhang HN. Stroke-like migraine attacks after radiation therapy syndrome. Chin Med J (Engl) 2015; 128 (15) 2097-2101
- 3 Black DF, Bartleson JD, Bell ML, Lachance DH. SMART: stroke-like migraine attacks after radiation therapy. Cephalalgia 2006; 26 (09) 1137-1142
- 4 Armstrong AE, Gillan E, DiMario Jr FJ. SMART syndrome (stroke-like migraine attacks after radiation therapy) in adult and pediatric patients. J Child Neurol 2014; 29 (03) 336-341
- 5 Ota Y, Leung D, Moritani T, Capizzano AA. Atypical imaging findings of presumed stroke-like migraine attacks after radiation therapy syndrome in the brainstem. Neuroradiology 2021; 63 (08) 1377-1381
- 6 Black DF, Morris JM, Lindell EP. et al. Stroke-like migraine attacks after radiation therapy (SMART) syndrome is not always completely reversible: a case series. Am J Neuroradiol 2013; 34 (12) 2298-2303
- 7 Bartleson JD, Krecke KN, O'Neill BP, Brown PD. Reversible, strokelike migraine attacks in patients with previous radiation therapy. Neuro-oncol 2003; 5 (02) 121-127
- 8 Fan EP, Heiber G, Gerard EE, Schuele S. Stroke-like migraine attacks after radiation therapy: a misnomer?. Epilepsia 2018; 59 (01) 259-268
- 9 Farid K, Meissner WG, Samier-Foubert A. et al. Normal cerebrovascular reactivity in stroke-like migraine attacks after radiation therapy syndrome. Clin Nucl Med 2010; 35 (08) 583-585
- 10 Thomsen LL, Eriksen MK, Roemer SF, Andersen I, Olesen J, Russell MB. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002; 125 (Pt 6): 1379-1391
- 11 Thomsen LL, Ostergaard E, Olesen J, Russell MB. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology 2003; 60 (04) 595-601
- 12 Meletti S, Monti G, Mirandola L, Vaudano AE, Giovannini G. Neuroimaging of status epilepticus. Epilepsia 2018; 59 (Suppl. 02) 113-119
- 13 Rheims S, Ricard D, van den Bent M. et al. Peri-ictal pseudoprogression in patients with brain tumor. Neuro-oncol 2011; 13 (07) 775-782
- 14 Ramachandran R. Neurogenic inflammation and its role in migraine. Semin Immunopathol 2018; 40 (03) 301-314
- 15 Colman I, Friedman BW, Brown MD. et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ 2008; 336 (7657): 1359-1361
- 16 Karimi N, Tavakoli M, Charati JY, Shamsizade M. Single-dose intravenous sodium valproate (Depakine) versus dexamethasone for the treatment of acute migraine headache: a double-blind randomized clinical trial. Clin Exp Emerg Med 2017; 4 (03) 138-145
- 17 Sadighi ZS, Ness KK, Hudson MM. et al. Headache types, related morbidity, and quality of life in survivors of childhood acute lymphoblastic leukemia: a prospective cross sectional study. Eur J Paediatr Neurol 2014; 18 (06) 722-729
- 18 Khan RB, Merchant TE, Boop FA. et al. Headaches in children with craniopharyngioma. J Child Neurol 2013; 28 (12) 1622-1625
- 19 Singh TD, Hajeb M, Rabinstein AA. et al. SMART syndrome: retrospective review of a rare delayed complication of radiation. Eur J Neurol 2021; 28 (04) 1316-1323
- 20 Willard VW, Berlin KS, Conklin HM, Merchant TE. Trajectories of psychosocial and cognitive functioning in pediatric patients with brain tumors treated with radiation therapy. Neuro-oncol 2019; 21 (05) 678-685